| Want to jump right to here next time? Bookmark: www.canpku.org/education/treatments/hcu |
HCU Treatments and Therapies in Canada
Classical Homocystinuria (HCU) is most commonly due to cystathionine beta-synthase (CBS) deficiency. Treatment is individualized and guided by a metabolic clinic. Management focuses on lowering homocysteine levels, supporting healthy growth and development, and reducing the risk of complications (including blood clots).
Page focus: This page focuses primarily on classical homocystinuria due to cystathionine beta-synthase (CBS) deficiency, which is the most commonly recognized form of HCU managed with medical nutrition therapy, vitamin therapy, and homocysteine-lowering treatment. Other causes of elevated homocysteine (such as certain cobalamin-related disorders or severe MTHFR variants) may require different management approaches. Your metabolic clinic can clarify which diagnosis applies to you.
Important: Treatment decisions depend on HCU type (including whether a person is B6-responsive), age, biochemical stability, clinical history (including clot risk), and ongoing lab monitoring. Always follow your metabolic clinic’s recommendations.
Canada check: Drug availability and coverage can vary by province/plan. Your clinic can confirm what applies to your HCU type and situation. You can also verify authorized/marketed drugs using the Health Canada Drug Product Database (DPD): Search the DPD.
Core treatment approaches
For many individuals with HCU, treatment may include medical nutrition therapy, vitamin/cofactor therapy (when appropriate), a homocysteine-lowering medication (betaine), and long-term monitoring. Your clinic will individualize targets and treatment goals.
Dietary management and medical nutrition
In pyridoxine (vitamin B6) non-responsive HCU, a methionine-restricted diet may be recommended. This often includes specialized metabolic formula and careful planning to meet nutrition needs while controlling methionine intake. Diet targets vary by age, growth, and lab monitoring.
Related education: Nourish | Low Protein Meal Planning Tools
Vitamin therapy (B6 responsiveness) and supportive vitamins
Some individuals have pyridoxine-responsive HCU. In these cases, pyridoxine (vitamin B6) may reduce homocysteine levels and improve biochemical control (dose and monitoring are clinic-directed).
Your clinic may also recommend folic acid (folate) and vitamin B12 (cobalamin) as part of a complete management plan, depending on labs and individual needs.
Tip: Do not start or change high-dose vitamins without clinic guidance. Dosing varies and should be monitored.
Homocysteine-lowering medication: betaine
Betaine (medical name: betaine anhydrous) can be used to help lower homocysteine levels. It may be used alongside diet and/or vitamin therapy, depending on the person’s HCU type and lab results.
Brand example: CYSTADANE® (betaine anhydrous) is a recognized product used for homocystinuria management. Your clinic can advise whether this is appropriate and how coverage works where you live.
Note: Betaine therapy requires clinic monitoring. Some people may develop elevated methionine levels on betaine, so labs and targets should be clinic-directed.
Reducing clot risk and managing special situations
A major medical concern in HCU is thromboembolism (blood clots). Good biochemical control is one part of risk reduction, but individual risk varies. Your healthcare team may discuss additional planning for higher-risk situations such as surgery, immobility, pregnancy/postpartum, or a prior history of clots.
Tip: Ask your clinic what warning signs matter most for your family and what to do if symptoms occur.
Hospital care and emergency planning
Even when day-to-day management is stable, emergency planning matters. Families and adults should keep an updated emergency letter and know which hospital to attend in urgent situations.
For practical planning support, families may find our emergency preparation resource helpful:
This toolkit supports conversations with your clinic and local hospital. Always individualize emergency planning with your care team. We thank HCU Network America for their support in sharing this resource.
In hospital settings, care may focus on urgent evaluation and treatment of complications (for example, suspected blood clots), support during surgery or severe illness, hydration and nutrition planning, and coordination with metabolic specialists. If anticoagulation or other acute treatments are needed, they are directed by the hospital team based on the individual situation.
Ongoing monitoring and long-term care
Clinics use laboratory monitoring (including homocysteine and related markers) to assess biochemical control and adjust treatment. Eye health, bone health, growth, development, and overall wellbeing are monitored across life stages.
Transition to adult care and pregnancy planning should be coordinated with metabolic and specialist teams.
About our scope: CanPKU+ currently focuses on rare metabolic disorders that are treated, at least in part, through medical nutrition therapy including protein modification and specialized formula. If emerging needs arise within related metabolic conditions, we are open to expanding educational coverage when there is a clear community need and appropriate clinical guidance.
Research, trials, and registries
Looking for research studies, registries, or clinical trials (including studies that may be recruiting)? We track current research and study opportunities on our dedicated page:
HCU Studies & Trials HCU Registry
Optional external resources:
Sources and references
- Health Canada – Drug Product Database (DPD)
- Health Canada – Drug & Health Product Portal: CYSTADANE
- Health Canada – Product Monograph: CYSTADANE (betaine anhydrous)
- Orphanet – Homocystinuria due to CBS deficiency (overview + treatment approach)
- Journal of Clinical Pathology (BMJ) – Homocystinuria diagnosis and management (review)
External links are shared for education and support. CanPKU+ does not control external content. Always confirm medical guidance with your metabolic clinic.
Research, trials, and registries
Looking for research studies, registries, or clinical trials (including studies that may be recruiting)? We track current research and study opportunities on our dedicated page:
HCU Studies & Trials HCU Registry
Optional external resources: